Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature
- 6 September 2007
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 22 (2) , 459-461
- https://doi.org/10.1038/sj.leu.2404934
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trialsLeukemia, 2007
- Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression ProfilingCancer Research, 2007
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeBlood, 2007
- A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1Blood, 2006
- The molecular classification of multiple myelomaBlood, 2006
- The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cellsBlood, 2006
- Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaBlood, 2005
- CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myelomaBlood, 2005